Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tefferi

Showing results (231-240 of 346) with videos related to

Pageof 35
Sort By:
Blood|March 27, 2001
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasiaA Tefferi, M A Elliot, S Y Yoon, et al.
Leukemia|November 6, 2010
A phase-2 trial of low-dose pomalidomide in myelofibrosisK H Begna, R A Mesa, A Pardanani, et al.
Leukemia|April 5, 2014
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategiesA P Im, A R Sehgal, M P Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitroP A Svingen, A Tefferi, T J Kottke, et al.
Blood Cancer Journal|December 29, 2017
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patientsS Cerquozzi, D Barraco, T Lasho, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
British Journal of Haematology|November 14, 1997
The effects of anagrelide on human megakaryocytopoiesisL A Solberg, A Tefferi, K J Oles, et al.
Leukemia|April 30, 2016
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencingA Pardanani, T Lasho, E Wassie, et al.
Leukemia Research|February 13, 2001
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndromeA Tefferi, M A Elliott, D P Steensma, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methodsV F Fairbanks, G G Klee, G A Wiseman, et al.
Pageof 35

Showing results (231-240 of 346) with videos related to

Sort By:
Pageof 35
Blood|March 27, 2001
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasiaA Tefferi, M A Elliot, S Y Yoon, et al.
Leukemia|November 6, 2010
A phase-2 trial of low-dose pomalidomide in myelofibrosisK H Begna, R A Mesa, A Pardanani, et al.
Leukemia|April 5, 2014
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategiesA P Im, A R Sehgal, M P Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitroP A Svingen, A Tefferi, T J Kottke, et al.
Blood Cancer Journal|December 29, 2017
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patientsS Cerquozzi, D Barraco, T Lasho, et al.
Leukemia|May 15, 2007
The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1J Pan, A Quintás-Cardama, T Manshouri, et al.
British Journal of Haematology|November 14, 1997
The effects of anagrelide on human megakaryocytopoiesisL A Solberg, A Tefferi, K J Oles, et al.
Leukemia|April 30, 2016
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencingA Pardanani, T Lasho, E Wassie, et al.
Leukemia Research|February 13, 2001
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndromeA Tefferi, M A Elliott, D P Steensma, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methodsV F Fairbanks, G G Klee, G A Wiseman, et al.
Pageof 35